Gaviscon Tablet, Chewable
NDC Package 0135-0430-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Gaviscon (aluminum hydroxide and magnesium carbonate) tablets is a medication used to treat the symptoms of too much stomach acid such as stomach upset, heartburn, and acid indigestion. This formulation utilizes a tablet, chewable delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0135-0430 and is authorized under FDA application M001.

Identification & Billing

NDC Package Code
0135-0430-03
Package Description
100 TABLET, CHEWABLE in 1 BOTTLE
Product Code
11-Digit Billing Format
00135043003
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 212978 - Gaviscon Extra Strength 160 MG / 105 MG Chewable Tablet
  • RxCUI: 212978 - aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet [Gaviscon]
  • RxCUI: 212978 - Gaviscon Extra Strength (aluminum hydroxide 160 MG / magnesium carbonate 105 MG) Chewable Tablet
  • RxCUI: 308072 - aluminum hydroxide 160 MG / magnesium carbonate 105 MG Chewable Tablet

Clinical Specifications

Proprietary Name
Gaviscon Extra Strength
Non-Proprietary Name
Aluminum Hydroxide And Magnesium Carbonate
Substance Name
Aluminum Hydroxide; Magnesium Carbonate
Dosage Form
Tablet, Chewable - A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
This medication is used to treat the symptoms of too much stomach acid such as stomach upset, heartburn, and acid indigestion. Aluminum and magnesium antacids work quickly to lower the acid in the stomach. Liquid antacids usually work faster/better than tablets or capsules. This medication works only on existing acid in the stomach. It does not prevent acid production. It may be used alone or with other medications that lower acid production (including H2 blockers such as cimetidine/ranitidine and proton pump inhibitors such as omeprazole).

Regulatory & Marketing

Labeler Name
Haleon Us Holdings Llc
Product Type
Human Otc Drug
FDA Application #
M001
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-13-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0135-0430-03 identifies a specific commercial package of 100 tablet, chewable in 1 bottle of Gaviscon Extra Strength, a human over the counter drug labeled by Haleon Us Holdings Llc. This tablet, chewable is formulated for oral use and contains aluminum hydroxide; magnesium carbonate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on June 13, 2011. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat the symptoms of too much stomach acid such as stomach upset, heartburn, and acid indigestion. Aluminum and magnesium antacids work quickly to lower the acid in the stomach. Liquid antacids usually work faster/better than tablets or capsules. This medication works only on existing acid in the stomach. It does not prevent acid production. It may be used alone or with other medications that lower acid production (including H2 blockers such as cimetidine/ranitidine and proton pump inhibitors such as omeprazole).

How is this Haleon Us Holdings Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00135043003. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0135-0430-03
11-Digit CMS (5-4-2)
00135-0430-03

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.